Loss of WNT5A has been associated with a poor prognosis in a various cancers, including breast and colon cancer, neuroblastoma, and leukemia, indicating that WNT5A might play a tumor-suppressive role in these malignancies [114]. Here, WNT5A is linked to leukemia.